To a great extent, our phenotype is determined by our genetic material. Many genotypic modifications may ultimately become manifest in more or less pronounced changes in phenotype. Despite the importance of how specific genetic alterations contribute to the development of diseases, surprisingly little effort has been made towards exploiting systematically the current knowledge of genotype-phenotype relationships. In the past, genes were characterized with the help of so-called "forward genetics" studies in model organisms, relating a given phenotype to a genetic modification. Analogous studies in higher organisms were hampered by the lack of suitable high-throughput genetic methods. This situation has now changed with the advent of new screening methods, especially RNA interference (RNAi) which allows to specifically silence gene by gene and to observe the phenotypic outcome. This ongoing large-scale characterization of genes in mammalian in-vitro model systems will increase phenotypic information exponentially in the very near future. But will our knowledge grow equally fast? As in other scientific areas, data integration is a key problem. It is thus still a major bioinformatics challenge to interpret the results of large-scale functional screens, even more so if sets of heterogeneous data are to be combined. It is now time to develop strategies to structure and use these data in order to transform the wealth of information into knowledge and, eventually, into novel therapeutic approaches. In light of these developments, we thoroughly surveyed the available phenotype resources and reviewed different approaches to analyzing their content. We discuss hurdles yet to be overcome, i.e. the lack of data integration, the missing adequate phenotype ontologies and the shortage of appropriate analytical tools. This review aims to assist researchers keen to understand and make effective use of these highly valuable data.
A Historical Perspective
Phenotypes have been a subject of research ever since ancient Greek physicians such as Hippocrates (460-370 BC), Celsus (25 BC-50 AD), and Galen (130-201 AD) took an interest in meticulously describing and studying the human body and associated illnesses with physical causes [1] . It was only in the 19 th century, however, that scientists started to systematically examine phenotypes for their origins. By minutely describing the differences and common traits of different species, Charles Darwin (1809-1882) postulated his theory of evolutionary selection which holds that variation within species occurs randomly and that the survival or extinction of each organism is determined by that organism's ability to adapt to its environment [2] . Although his renowned book was entitled 'The Origin of Species', he never explained the actual origin of species or how heritable changes were passed on to subsequent generations, a fact heavily disputed at the time. By examining successive generations of peas, Gregor Mendel (1822-1884) observed that specific 'traits' of peas were passed on from one generation to the next and recurred in certain numerical ratios. To explain his results, he distinguished between the internal state ('genotype') and the external appearance ('phenotype'). He came up with the ideas of dominance and segregation postulating that offspring receive different sets of discrete 'hereditary factors' ('genes') from parents, and th century, when they were independently rediscovered by Hugo de Vries, Carl Correns and Erich von Tschermak [3] . It was the Danish botanist Wilhelm Johannsen who in 1909 coined the terms phenotype and genotype (both derived from Greek genein meaning 'to give birth' and phanein 'to show') and later, in 1911, introduced the distinction between genotype as a descriptor of the genome (describing the process of inheritance) and phenotype as a descriptor of the phenome (describing the process of development) [4] . Thus, in the most general sense, a phenotype is the expression of an organism's individual genetic blueprint under varying environmental influences.
It is now well accepted that there is a close relationship between genotype and phenotype. We are accustomed to defining diseases by a sum of symptoms (phenotype) and try to trace changes in phenotype back to their genetic origin. It is thus common practice that researchers define a phenotype by only that very small set of phenotypic characteristics that differ at the clinical, cellular, or molecular level from a fictitious average within a species. Our currently limited ability to fully describe any given individual's entire genome and phenome leaves us no other choice than to learn to live with partial data in this area. This is also why the term genotype is often incorrectly used for a single genetic change at a certain site in the genome (as if compared to a 'reference genome') and phenotype as a synonym for a certain phenotypic characteristic that is different as if compared with a hypothetical average individual of that species. Unfortunately, researchers typically fail to report all other observable changes unrelated to their specific question. Another limitation comes from the fact that for most phenotype data collected so far, the environmental contributions are either neglected or, in case of model organisms, kept to a minimum using standardized laboratory conditions.
The Complexity Of Genotype/Phenotype Connections
Our growing knowledge about the complexity of genetic interactions and the inter-individual genetic variance reflects our daily experience of the high degree of phenotypic individuality within the species Homo sapiens. It is this complexity that leaves us with little hope for unambiguous genotype-phenotype relationships: that a mutation in one gene would lead to a single clear-cut change in phenotype.
By using the fact that some phenotypes are traceably inherited (so-called 'Mendelian' or 'monogenic' diseases), positional cloning techniques have led to the identification of roughly 1,200 disease-causing genes [5] . Unfortunately, their genotype-phenotype relationships are not always as obvious as one might imagine. Different single nucleotide polymorphisms (SNPs) in the same locus have been shown to cause very different phenotypes (e.g. mutations in Drosophila's shaker gene lead to a reduced sleep rate or to shaking legs after etherization [6] ) or, if less pronounced, may lead to subtle sub-phenotypes of a disease (e.g. to mild or severe muscular dystrophy [5] ). Furthermore, combinations of correlated SNPs (so-called haplotypes) may 'fine-tune' the final phenotypic outcome of a disease-causing SNP or explain differential disease susceptibility [5, 7, 8] . For example, phenylketonuria (PKU) is considered a classic monogenic disease caused by several different mutations in the enzyme phenylalanine hydroxylase (PHA). However, even siblings who share an identical PHA genotype show 'widely differing phenotypes' [9] [10] [11] [12] . For PHA, there is a locus-specific mutation database (PHAdb) listing 498 mutations for this locus alone [13, 14] , most of which are presumed to be disease-causing [11, 15] . There are hints that the 'remarkable phenotypic variability' [12] within this monogenic disease may also be influenced by other genetic factors [12, 16] . Another such example for a 'not-so-simple' genotype/phenotype relationship of a monogenic disease is thalassaemia, reviewed in [12] . If sets of SNPs are inherited together as haplotypes, the individual phenotypic contribution of each SNP within this haplotype is further obscured. Nevertheless, haplotype analysis is an opportunity to measure the effects en-bloc [8] and detailed elucidation of haplotypes is currently underway within the International HapMap Project [17] . In short, 'simple Mendelian inheritance is often not so simple' [5] .
In contrast to the monogenic diseases, phenotypes of complex diseases are much harder to pinpoint unequivocally to the relevant variant genomic sites as the signal spreads over several loci. Accordingly, for many multifactorial and 'complex diseases' like diabetes, Alzheimer's disease, stroke, psychiatric disorders, or obesity, the complete picture of the genotype-phenotype relationships remains largely unsolved. Here, the contributions of a gene to the disease are usually detected through studies of larger populations and are rather termed association or susceptibility underlining the lack of a true understanding of the contribution. Variability in two phenotypes despite identical sequences of the phenotype-causing gene(s) are often declared to be a consequence of the 'different genetic background', hereby referring to unexplained effects from the rest of the genome (e.g. epigenetic influences). Association or susceptibility data of complex diseases are difficult and expensive to measure and not the subject of this review. Even in a perfect setting, two organisms with an identical genotype having experienced development in an ideal environment would still differ slightly due to the stochastic nature of the underlying processes (so-called phenotypic plasticity or polyphenism [18] ). This review focuses on phenotype data from genotypephenotype relationships where the genetic component plays a proportionally much more pronounced role for the phenotype than e.g. the epigenetic or environmental influences.
Ways of Collecting Phenotype Data: Going HighThroughput?
Despite the difficulties of mapping a phenotype to the underlying genotype and the challenges of describing phenotypes consistently and in a highly standardized manner, enormous efforts have been undertaken to collect and generate phenotype data [19] [20] [21] [22] . The fruit fly is certainly the most impressive example. One genetic screen to identify mutations with developmental phenotypes in Drosophila [23] was even awarded the Nobel prize. A battery of methodologies (reviewed in [24] ) has been employed over the last few decades to collect mutants and describe them in great detail. These data have been tremendously helpful in working out the genotype-phenotype relationship with the help of so-called forward genetics. In contrast, analogous studies in higher mammals have been hampered by much longer life spans, a lack of sophisticated methods, or for ethical reasons. Here, systematic examinations of transgenic or knockout animals as well as comprehensive SNP analyses have been successful but limited in number, especially since there was a lack of highthroughput methods to generate vast quantities of data.
This situation has now changed dramatically with the advent of RNA interference (RNAi) allowing specific silencing of one gene at a time and observing the phenotypic outcome [25] . The development of RNAi technologies for mammals, where now the immune response against long dsRNA is avoided by using short 21-23nt long siRNAs [26] , has enabled us to generate large amounts of mammalian invitro data [27] [28] [29] [30] . As RNAi is applicable at the cellular level, it overcomes the limiting generation time of higher mammals and has proved to be useful in filling gaps in our understanding of genotype-phenotype relationships [25, 26, 31] . The 'range of biological read-outs that can be used to infer function' is nearly unlimited and is one of the most important aspects of large RNAi screens [32] . Due to the availability of whole genome sequences for many model organisms as well as for humans, the number of projects relating phenotypes with genotypes using RNAi is rising steadily (see [33] for a review of the plethora of genomewide RNAi studies). From the number of RNAi-based phenotypes elucidated in the last few years, an avalanche of RNAi-based phenotype data can be extrapolated: for instance, 25 RNAi phenotypic assays in a genome-wide screen ( 20,000 genes) in only 8 of the most important model organisms would lead to the accumulation of 4 million 'phenotypes'.
Other potent screening technologies for turning out phenotypes in high numbers are the recently started mutagenesis programs using chemical agents such as ethylmethanesulphonate (EMS) or N-ethyl-N-nitrosourea (ENU). Both EMS and ENU induce point mutations in DNA, leading to a variety of genetic lesions that are expressed as a complete loss of function, a partial loss of function, or a gain of function alleles [34] . Three NIH Mutagenesis Centers are equipped to screen over 13,000 mice each year and have thus generated ~500 lines of interest for neuroscience mutagenesis alone [35] . The NCI and the National Human Genome Research Institute have announced to commit 50 million USD to collect and analyze all genetic mutations found in human cancers. Other largescale projects like the Mouse Phenome Project [36] and Eumorphia [37] have started to coordinate world-wide efforts for the generation of standardized phenotype data published in purpose-orientated databases. The call for an analogous project for human phenotypes, namely the Human Phenome Project [38] was made in 2003 and this project can be expected to get off the ground in the near future.
What Makes Phenotype Data So Highly Valuable?
A growing number of publications has underlined the importance of well-structured and standardized phenotype data and the call for robust analytical tools for phenotypic research is steady [39] [40] [41] . Some exciting phenotype research has unraveled the potential and the scientific value of comparing phenotypes from different experiments.
Eggert et al. [42] have combined a functional genomics and a chemical genetic screen to simultaneously identify targets in and inhibitors of cytokinesis in Drosophila melanogaster. The beauty of their approach lies in the systematic comparison of the resulting phenotypes from both data sets. In both screens, they observed cells with two nuclei as a result of cytokinesis-defect mitosis. After classification of all sub-phenotypes with regard to very subtle differences, they could identify genes as new members of known pathways relevant to cytokinesis on the one hand, and small molecules with an effect on the same pathway on the other hand.
In another study, Cirelli et al. [6] have identified out of 9,000 Drosophila melanogaster mutants with abnormally reduced daily sleep amount. One of the most extreme mutants was termed 'minisleep'. The mutation mapped to the X-chromosome and was inherited recessively. The investigators were attentive enough to notice that the minisleep mutants 'exhibited a transient shaking of the legs and scissoring of the wings when recovering from diethyl ether anesthesia'. This seemingly unrelated behavior, however, was the key to finding the gene responsible for minisleep. By that time, four genes on the X-chromosome, when mutated, were known to display a 'shaking phenotype after etherization'. One of these candidates, shaker, did indeed contain both the mutation responsible for the shaker phenotype as well as another new mutation causing the minisleep phenotype. All 'sleepers' were also 'shakers', and minisleep mutants could be rescued with a corresponding shaker + transgene. It is noteworthy that it is not a straightforward database search to identify genes on chromosome X responsible for shaking legs after etherization when mutated. A manual literature review can be time-consuming and in our last example we used an optimized search string for part of the problem, i.e. 'shak* and (leg* or wing*) and ether*', with no results in PubMed and only a single correct gene hit using a general-purpose text-mining tool (EBIMed [43]).
Expression profiles as quantitative phenotypic traits of a gene's behavior (so-called eQTLs) can lead to clinically relevant insights if used systematically in combination with clinical traits. By these means, Schadt et al. were able to identify targets for obesity [44, 45] . Valk et al. [46] found molecular signatures from gene expression profiles of acute myeloid leukemia (AML) patients, by clearly discriminating 16 patient groups within AML. This may directly improve the therapeutic and prognostic information of the commonly used disease classification methods which can correctly classify patients in only 50% of cases.
In a recent RNAi screen, Sieburth et al. [47] found 185 genes relevant to the function and development of neuromuscular junctions in Caenorhabditis elegans. They determined functional profiles for these genes by comparing and clustering the phenotypic observations after RNA interference. Hierarchical clustering led them to functionally annotate 132 genes previously not known to be involved in synaptic transmission.
To analyze RNAi screening results for Caenorhabditis elegans, Gunsalus et al. [39] broke down the phenotype data into one or more of 47 basic 'phenotypic characters' assigning two discrete values for either their absence or presence. Each gene can then be assigned a 'phenotypic signature' or fingerprint. A tool termed 'PhenoBlast', due to its conceptual similarity with the popular sequence alignment tool BLAST, can then calculate similarities between phenotypic fingerprints. This approach enables the grouping of genes by their phenotypic outcome rather than sequence homology and thus identifying the genes involved in a given pathway or biological function.
The Potential of Comparative Phenomics
This intriguing work shows that comparing phenotypes can bring seemingly unrelated observations together and makes a convincing case for the importance of comparative phenomics. The systematic large-scale analysis of genes in mammalian in-vitro systems adds knowledge on gene function to the already existing classical phenotype data. However, for this endeavor to be successful, it is a prerequisite to have richly annotated, highly structured and well-organized phenotype/genotype data. Currently, these data are scattered over many species-specific databases and heterogeneous literature or in the respective supplementary information.
The time has now come to develop strategies to systematically use these data and transform them into knowledge and eventually into novel therapeutic approaches. To assist researchers keen on understanding phenotype data, we seek to review the available resources, take a look at how they need to be transformed to enable data mining and finally explore adequate analytical tools.
PHENOTYPE ANALYSIS: DATA AND TOOLS The World-Wide Phenotype Data Inventory
The largest repository of phenotype data by far is biomedical literature. Unfortunately, the free-text corpus accessible for computer-aided searches covers only a minor part, namely the abstracts. Even if full-text access to the majority of publications were available, identification and automatic extraction of phenotype data from that text corpus remains challenging as attempts to develop algorithms and tools for this purpose have shown [48, 49] .
Whereas text-mining for gene names ('entity identification') is now achievable due to naming conventions (HGNC [50] ) but still remains challenging due to irregularities, homonyms, etc. [51] [52] [53] [54] , text-mining in the field of phenotypes suffers from descriptive data, i.e. a complete lack of an agreed nomenclature. Even given the existence of such an ontology, it is notoriously difficult to assign ontology terms to the corresponding biomedical literature with acceptable recall as a recent text-mining competition (BioCreAtivE) has shown [55, 56] . Curator teams from the organism-specific databases, however, have done an impressive job in collecting functional genomics and phenotype data from the literature. By doing so, they have already provided much faster and simpler access to the phenotype data around each gene for a given organism. Table 1 gives an overview of most of them.
For mice, the MGI group at Jackson Laboratory has assigned 43,652 phenotypic terms from the Mammalian Phenotype Ontology [95] to 12,557 genotypes from roughly 5,000 unique genes [36, [75] [76] [77] [78] [79] [80] 95] . Most of these data are derived from genetically engineered k.o. mice or naturally occurring mutants.
The rat genome database aims at integrating its genomics data with phenome data, covering information on more than 15,886 rat genes, 988 strains, and 977 QTLs [72] [73] [74] 96] . It now also offers a special disease portal presenting roughly 1,000 disease-causing rat genes in their genomic context. WormBase [81] [82] [83] [84] [85] currently contains 59,885 wellorganized RNAi phenotypes from Caenorhabditis elegans, gathered from public screens [97] [98] [99] [100] [101] [102] and data resources like PhenoBank [86] , along with data on 2,595 mutant phenotypes and 8,416 strains. By this, the WormBase group has shown impressively the potential of integrating RNAi data from various screens and sources.
As mentioned above, large mutant screens based on different methodologies (reviewed in [24] ) have led to a rich database for Drosophila melanogaster. The FlyBase group has associated roughly 150,000 phenotypic statements with genes and presents 22,954 mutant aberrations and 27,200 stocks [87] [88] [89] [90] [91] . R. Drysdale has given a detailed guide on how to access phenotype data in FlyBase [89] . In contrast to WormBase, RNAi data from genome-wide screens in Drosophila melanogaster are being kept separately in FlyRNAi [103] which is run by the Drosophila RNAi Screening Center at Harvard Medical School where some 2,000 RNAi phenotypes from a number of genome-wide RNAi screens are currently on display.
More than 3,000 Danio rerio (zebrafish) phenotypes, a helpful organism, e.g. for angiogenesis, can be found in the Zebrafish Information Network database [104, 105] . DictyBase [106, 107] for Dictyostelium discoideum (slime mold) contains 350 genes with associated phenotype data.
For Homo sapiens, the phenotype data resources are more diverse (Clinical data as a phenotype resource are being omitted here). For a long while, the first address has [110, 111] group has announced to go one step further in the future, annotating these SNPs with their phenotypic consequences [40] . dbSNP and HGVbase exchange their SNP content bidirectionally. SNPeffect [112] , in contrast, tries to predict the effects of SNPs on functional or physicochemical properties of the corresponding proteins. The Pharmacogenetics and Pharmacogenomics Knowledge Base (PharmGKB) compiles data on how genetic variation contributes to variation in drug response [63] [64] [65] [66] [67] [68] [69] . Currently, PharmGKB holds phenotype information for 409 genes.
There are additional databases on human diseases, genetic variations and phenotypes but they are either too specialized to be mentioned here, or do not connect the phenotypes to the genotypes, or have restricted access. Many of them are listed [113] or reviewed elsewhere [114] [115] [116] .
Taken together, the scope of what can be considered 'phenotype data' is badly defined (if at all) and can range from gene expression data at the molecular level to clinical patient records at organism or even population level. This adds to the number and complexity of phenotype data that can be included in the inventory listed above, and the resulting data heterogeneity explains why integration of phenotype data has not really been addressed so far. Given the plethora of species-specific databases and locus-specific databases with phenotype content, cross-species databases are the next logical step towards comparative phenomics. Common to the genome databases mentioned above is the lack of vigorous exploitation of the existing orthology information to ease phenotype comparison between species. Besides OMIA [117] , an animal equivalent of OMIM on a smaller scale, the first cross-species phenotype database on a larger scope, PhenomicDB [57] , was created in 2004 and is, still, the only one of its kind. PhenomicDB allows researchers to look simultaneously at all available phenotypes for an orthologous gene group. It encompasses classical phenotype and RNAi data gathered from OMIM and many of the model organism genome databases or published RNAi data sets mentioned above.
Phenotype Data Handling and Mining
The question arises as to how to handle the wide scope of data types scattered around the world. Do we have the appropriate tools at hand to systematically take advantage of them? The ultimate goal must, of course, be to finally open this treasure chest and gain access to the wealth of buried information and transform it into new hypotheses and knowledge.
Three steps are required to enable general data handling independent of data sources. In the first step, data sources need to be gathered (for optimal coverage), aligned (e.g. to remove redundancy), mapped onto a gene index and ultimately integrated at a semantic level such that equivalent data is eventually found in the same place. The next step aims at making the data comparable by introducing ontologies and other data structures that relate the data points (e.g. orthologies). Only then, as a final step, can robust data mining methods be employed systematically to exploit the data based on statistical analyses and/or direct or crossspecies functional comparison.
Step 1: Integration
In general, and not limited to the phenotype data domain, different data integration approaches can be applied: data warehousing (collating all data in a single large database) [118] and federation of independent databases [119] . These approaches have different pros and cons which are discussed elsewhere [120] . Integration of phenotype data, however, is a notoriously difficult and time-consuming endeavour, especially for cross-platform or cross-species data [57, [121] [122] [123] , some attempts will be discussed in this section. For illustration purposes, we show available phenotype information for cdk-7 of Caenorhabditis elegans in 'WormBase' [82] , 'PhenoBank' [86] , and 'RNAi Database' [39] , and the corresponding yeast and mouse orthologue in Fig. 1 .
Beroud et al. [124, 125] developed a generic and freely available software system, called UMD for Universal Mutation Database, for researchers who wish to generate their own locus-specific database. Under this roof, twelve such independent locus-specific databases have been gathered by August 2005 [125] and can be searched simultaneously through an integrative software module (UMD central). As a proof of principle, Tao et al. [126] have semi-automatically collected subsets of phenotype data from OMIM and mouse-related entries from MEDLINE into a denormalized database in order to create an integrative view on these data. Their solution, called PhenoGenesviewer, is based on methods to further organize the phenotypes with lexical, conceptual, and semantic approaches [41] , selforganizing maps and hierarchical clustering analysis [127] by mapping phenotype vocabularies (SNOMED CT [128] [129] [130] [131] [132] [133] [134] [135] [136] [137] , UMLS [138] [139] [140] [141] [142] [143] and Phenoslim developed by the Mouse Genome Database group).
PharmGKB exemplifies how a wide range of data for one species (Homo sapiens) can be brought together to support phenotype research. PharmGKB reports on genes, diseases, drugs, pathways, and phenotype data sets and their mutual relationships. Apart from literature data, PharmGKB has gathered original phenotype data sets associated with 34 drugs, 409 genes and 16 diseases. Although the species- Fig. (1) . Available phenotype information for cdk-7 in different species-specific databases. Even equivalent phenotype information for Caenorhabditis elegans cdk-7 gene is presented in diverse ways across relevant databases, here 'RNAi Database' [39] , 'WormBase' [82] , and 'PhenoBank' [86] . Phenotype description for cdk-7 in other species (here Saccharomyces cerevisiae, CYGD [94] and Mus musculus, MGD [79] ) is characterized by species-specific terminology and a layout unique to each resource. The phenotype information is partially complementary, but mostly redundant. Assembling available phenotype information of the orthologue group for cross-species comparison is a time-consuming manual task. specific genome databases have already integrated phenotype data with genome data, the phenotype data cannot easily be compared between the species. In contrast, the PhenomicDB team has collected genotype/phenotype data from Saccharomyces cerevisiae, Caenorhabditis elegans, Drosophila melanogaster, Mus musculus and Homo sapiens databases, in a data-warehouse-like approach, enriched it with data from NCBI's Entrez Gene to allow for common gene indices and used HomoloGene [59] to put the genes in a phylogenetic relationship. In PhenomicDB, semantic integration is achieved by mapping all source data tables to a common database model merging or separating data to present it in a uniform way. In total, PhenomicDB reports on nearly 200,000 semantically integrated phenotypes connected with 80,719 genes from several organisms. Interestingly, by exploiting orthologies, it is able to report a human or an orthologue phenotype for nearly one third (9,971) of the human genes. All integrative phenotype databases described above use the gene level as the conceptual granularity for the genotype. Although this is a pragmatic approach, it will have to be revisited in the long term, when SNPs and intergenic regions may gain relevance for phenotypes as well.
Step 2: Reducing Complexity by Using Ontologies
The most consistent way to structure large heterogeneous data or knowledge domains, is the creation of a useful ontology. The strength of ontologies and controlled vocabularies is their use beyond one system. The Mammalian Phenotype (MP) Ontology [95] is the major phenotype ontology available today but it was mainly developed for rats and mice. Fortunately, its potential goes beyond these two species. Its cellular phenotypes, for example, could at least partially be applied to other model organisms such as Drosophila melanogaster or Caenorhabditis elegans, opening up new perspectives for the use of this resource. Such an effort, however, could certainly not be maintained by the main MP contributors alone. Other promising public biomedical ontologies including more specialized phenotype ontologies (e.g. for cell type, plant trait or Drosophila development) can be found in the open biomedical ontologies (OBO) repository at http://obo.sf.net. Due to its special needs in the field of pharmacogenomics, PharmGKB has initiated its own ontology development [144] . In the long term, however, it seems important that the community will develop a common open resource to ensure data comparability. Gkoutos et al. have proposed a scheme for modeling combinations of orthogonal phenotype representations using further ontologies (e.g. such as the Phenotype and Trait Ontology (PATO) from OBO) to describe complex mutant phenotypes generated within the Eumorphia project [37, 145] . They also provide software (CRAVE) for the visualization of such a complex ontology [146, 147] . However, the main bottleneck remains that mostly species-specific ontologies (if at all) are used to describe phenotypes and hence phenotype annotation with a combined ontology is the challenge for the future. The Gene Ontology (GO) [148, 149] is a vivid example of the impact of an ontology on biomedical research in case a single ontology prevails within the community. Most of the databases listed in Table 1 provide gene ontology making it a useful bridge across them. Furthermore, as these ontology terms relate genes with biological processes or their molecular functions they could already be regarded as a basic phenotypic feature information.
Why are ontologies important for comparative phenomics? The free-text description used by researchers to document their phenotypic observations may differ strongly, allowing only manual comparison. Phenotypic results from one screen need to be abstracted to a level where comparison with results from other screens are enabled. A RNAi readout for apoptosis can be achieved with a TUNEL, a PARP cleavage, or an anoikis assay. Although the absolute values of each result are not comparable, they can be compared if abstracted to an ontological instance like 'decreased apoptosis (MP:0006043)'. Ontologies also allow for unambiguous identification of biological objects when synonyms are used as query terms.
Steps 1 and 2 are preliminary steps in order to enhance the quality and accessibility of available data and thus ease the turnout of results. In the past, prior to any analysis, the current status of phenotype resources required difficult manual intervention and curation of data subsets rather than a systematic workflow. In the next section we will describe analytical methods that have been applied to such tediously hand-curated phenotype data sets.
Step 3: Mining Phenotype Data
The well-structured manually curated data set of Sonnichsen et al. [86] , for example, was used to create a 'disease map', a graphical display of 45 disease categorieslike 'meiotic arrest'-with values characterizing each category-like 'passage through meiosis'. By this, a phenotype is described as the sum of 45 phenotypic features, each represented by either absence or presence calls. Such phenotypic features are ideally taken from phenotype ontologies or other adequate vocabularies/ontologies (e.g. functional classes in GO). This profiling system allows using current clustering methods to group genes based on their common phenotypic feature patterns as distance measure, associating genes of unknown function directly with specific disease categories. Such 'phenoclusters' (genes grouped according to functional annotation derived from RNA interference) were introduced in 2002 by Piano et al. [98] who found that 'phenoclusters correlate well with sequencebased functional predictions and thus may be useful in predicting functions of uncharacterized genes'. Clustering methods based on feature vectors have found broad application in the analysis of postgenomic data and are reviewed elsewhere [150] .
Prank et al. [151] have compared methods to determine phenotype-genotype relationships in order to predict genetic alterations that lead to adrenal hyperplasia from complex biochemical data. Using serum level profiles of steroid intermediates from 54 patients with heterozygous 21-hydroxylase (CYP21B) mutations versus healthy controls, they compared traditional clinical methods, traditional linear discriminant analysis and nonlinear methods, i.e. artificial neural networks, support vector machines, and k-nearest neighbor classifiers. They showed that the nonlinear statistical analyses performed with an accuracy of up to 83%, in contrast to prediction accuracy by clinical methods of 39% and of 64% by classical linear analysis.
Generally, in order to classify phenotype data based on vectorization of their phenotypic profile as illustrated in the above examples, different supervised machine learning methods are available. K-nearest neighbor (kNN) classification maintains a set of training cases in predefined classes (clusters) where each data point is nearest (in Euclidean distance) to the mean feature vector of that class. For a test case, the k nearest data points are computed and this new point is allocated to a class, depending on the prior classification of these k points by majority vote [152] . Artificial neural networks (ANN) are an extension of the standard K-means clustering procedure and take into account a 'neighborhood ranking' of the nearest vectors. The dynamic neighborhood ranking takes place during an inputdriven adaptation procedure of the reference vectors [153] . Support vector machines (SVM) realize pattern recognition between two classes by finding a decision function (hyperplane) determined by selected points from the training data, termed support vectors. In general, this hyperplane corresponds to a nonlinear decision boundary in the input space. While traditional techniques for pattern recognition are based on minimizing the empirical risk (i.e. on the attempt to optimize the performance on the training set), SVMs minimize the structural risk (i.e. the probability of yet-to-be-seen patterns to be classified correctly for an unknown probability distribution of the data) [154] . These machine-learning approaches can grasp well the typically nonlinear nature of the underlying complex genetic interactions by learning from a training set. Recently, Rodin et al. [155] have applied Bayesian belief networks to phenotype data consisting of plasma apolipoprotein E (apoE) levels from 702 African-Americans and 854 non-Hispanic whites. From 72 individuals, 20 variable sites in the apoE gene were included in the belief networks. Three SNPs could be singled out as most likely responsible for plasma apoE levels. This method can be used to reduce the number of candidates in an association study for a phenotype of interest, provided that reliable phenotype data are at hand. A belief network's topology shows a graphical relationship among variables (here SNPs and genes), or nodes, thus showing which variables are dependent on or conditionally independent of which other variables. Edges connecting nodes are therefore undirected and indicate dependence. The edge strength indicates the relative magnitude of the dependency between two variables, given the other interrelationships within the network. It therefore reflects a joint probability distribution among the nodes. Conveniently, an edge between two SNPs also indicates a linkage disequilibrium. By employing this approach, Rodin et al. could 'simultaneously take into account linkage disequilibrium while performing genotype-phenotype association analyses'.
Clare et al. [156] have applied supervised machine learning methods to the problem of predicting the functional classes of genes in Saccharomyces cerevisiae from phenotypic growth data. The data are combined from three different sources (TRIPLES [157, 158] , EUROFAN [159, 160] and MIPS [161] [162] [163] ) and represented as a vectorization of attributes (growth medium) and values (observed sensitivity or resistance of the mutant compared to the wild type). The classes were assigned from the MIPS functional catalogue. The accuracy of the learned rules were then estimated using phenotype data from deletion mutants of genes with known function. Eventually, Clare et al. could predict the function of 83 genes of hitherto unknown function with an estimated accuracy of at least 80%.
Troyanskaya et al. [164] developed MAGIC (Multisource Association of Genes by Integration of Clusters) as a general and flexible probabilistic framework to combine heterogeneous data sets for integrated analysis based on Bayesian networks. To illustrate its utility, clusters of Saccharomyces cerevisiae genes were formed using genetic and physical interactions, microarray, and transcription factor binding sites data with methods like Kmeans clustering, self-organizing maps, and hierarchical clustering. For these clusters, MAGIC created a posterior belief for whether a gene pair has a functional relationship, identifying a cluster of genes involved in ubiquitindependent protein catabolism, which provides 'potential functional annotation for an ORF present in that cluster (YGL004C), and confirms the recently added annotation for YNL311C'. Furthermore, they discovered a gene group involved in protein biosynthesis. In this cluster, 49 genes already annotated as involved in protein biosynthesis were found as well as 10 unknown genes. One could imagine using MAGIC also for integrated analysis of data sets with e.g. phenoclusters.
Another interesting field in phenotype analysis is pathway reconstruction. From only microarray expression profiles ('global transcriptional phenotypes'), groups have successfully used epistasis analysis to reconstruct topologies of pathways in organisms such as Dictyostelium discoideum [165] or Saccharomyces cerevisiae [166] . To that end, double mutants are generated and the distance of all their expression profiles to each of the profiles of the corresponding single mutants is determined. That single mutant closer to the double mutant is topologically downstream of the other single mutant. Full reconstruction of pathways with components not transcriptionally regulated, however, is only feasible if additionally external interventions such as RNA interference or gene knock-outs are applied and used as 'single-gene phenotypes' as shown by Markowetz et al. [167] .
In order to better understand Caenorhabditis elegans embryogenesis at a systems level, a large-scale integrative approach has been employed by Gunsalus et al. [168] . Data from protein interactions, gene expression clusters, and phenotypic RNAi profile similarities were incorporated to model one large gene/protein network said to have 'a high predictive value for novel gene functions'. To integrate three different types of functional relationships, graphs were built representing 661 embryogenesis genes as nodes connected by edges suggested by any evidence from the three data sets. Integration was accomplished by finding correlation among pairs of the same nodes in the different graphs. This last high-profile multi source approach gives us a first taste of the emerging power of comparative phenomics.
PERSPECTIVES
A thorough analysis of phenotype data is a next logical step towards understanding the nature of human disease and finding novel therapeutic approaches. The vast majority of the data generated so far have been gathered in free-text archives of biomedical literature and cannot be found in any structured phenotype database. A consistent approach on automated data extraction and conversion into a single structured repository has not yet been reported. In consequence, many groups have made great efforts to adapt specific parts of these data to their special scientific needs. And large-scale approaches using these data systematically have been hampered by the complex nature of the data and by the difficulties of integration and normalization. Issues that will have to be tackled range from compatibility of data types of the various resources to their systematic comparability. First attempts at systematic storage and comparison have been made, e.g. with PharmGKB and PhenomicDB, but these approaches still suffer from certain limitations, e.g. the lack of an appropriate and unifying ontology.
Rigorous amplification and application of ontologies are required to successfully apply innovative or classical tools to foster a more widespread use of phenotype data. To this end, an international consortium of phenotype research groups should be established, in order to solve the two most urgent needs in the field of comparative phenomics:
1.
To further develop a universal phenotype ontology.
2.
To set up an integrated phenotype data resource.
It has been shown in other fields that combined public efforts, e.g. the Human Genome Project, can achieve very high-stacked goals. Although this is an ambitious objective, this need has already been recognized by others [40] . The achievement of this goal is a necessary step if comparative phenomics should ever return the huge investments already made.
